Thiola EC (Tiopronin) Patent Expiration, LOE Window & CMS Spending

Thiola EC (Tiopronin) by Mission Pharmacal: FDA Orange Book LOE 2038-11-14, 3 AB generics, $39.3M 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorMission Pharmacal
FDA Application & PathwayN211843 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2038-11-14
Orange Book Patents (*PED Extensions)1 patents (0 *PED)
Active AB-Rated Generic Competitors3
2024 CMS Total Public Spend$39.3M
2024 Medicare Part D Spend$26.6M
2024 Medicaid Spend$12.7M
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel